Citation Impact
Citing Papers
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Triple-Negative Breast Cancer
2010 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
B‐CELL LYMPHOMA OF MALT TYPE: A REVIEW WITH SPECIAL EMPHASIS ON DIAGNOSTIC AND MANAGEMENT PROBLEMS OF LOW‐GRADE GASTRIC TUMOURS
1998
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
High-dose methotrexate: a critical reappraisal.
1987
Cytokines in cancer immunity and immunotherapy
2004
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
SYNTHESIS: Cancer research meets evolutionary biology
2009
The Treatment of Recurrent Unresectable and Malignant Meningiomas with Interferon Alpha-2B
1997
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase
2002
Tumor acidity, ion trapping and chemotherapeutics
2003
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
2006
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Male breast cancer
2006 Standout
Treatment of hairy-cell leukemia
1990
MutLα and Proliferating Cell Nuclear Antigen Share Binding Sites on MutSβ
2010 StandoutNobel
Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil
1995
Differential Specificities and Simultaneous Occupancy of Human MutSα Nucleotide Binding Sites
2004 StandoutNobel
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
1996
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Isolation of MutSβ from Human Cells and Comparison of the Mismatch Repair Specificities of MutSβ and MutSα
1998 StandoutNobel
DNA-dependent Activation of the hMutSα ATPase
1998 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Clonal evolution in cancer
2012 StandoutNature
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
1989
Breast cancer metastasis: markers and models
2005 Standout
Cytokines in clinical cancer immunotherapy
2018
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
2011
Role of Functional Imaging in the Management of Lymphoma
2011
The gastric marginal zone B-cell lymphoma of MALT type
2000
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
2005
UV Radiation Facilitates Methotrexate Resistance and Amplification of the Dihydrofolate Reductase Gene in Cultured 3T6 Mouse Cells
1984
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy
1978
Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission
2013
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Immunotherapy Through the Years
2017
Female Reproductive Potential after Treatment for Hodgkin's Disease
1981 Standout
The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide
2006
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells.
1984
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome
1989 StandoutNobel
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
2008
Normal diploid human and rodent cells lack a detectable frequency of gene amplification.
1990
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
Twenty years of MOPP therapy for Hodgkin's disease.
1986
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
2004
Methotrexate resistance and gene amplification. Mechanisms and implications
1986
Amplification of tandemly repeated origin control sequences confers a replication advantage on rDNA replicons in Tetrahymena thermophila.
1990 StandoutNobel
Gene amplification in cultured animal cells
1984
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Growth Factors and Cancer
1991 StandoutScience
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine
2007
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
The gastric marginal zone B-cell lymphoma of MALT type
2000
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Quantitative genetic analysis of tumor progression
1985
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
1990 StandoutNobel
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
1986
Amplification of Tandemly Repeated Origin Control Sequences Confers a Replication Advantage on rDNA Replicons in Tetrahymena thermophila
1990 StandoutNobel
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
1998
Mutational Activation of the K-rasOncogene
1987
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
2007
DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair
1997 StandoutNobel
Assessment and Significance of Mediastinal Bulk in Hodgkin's Disease: Comparison Between Computed Tomography and Chest Radiography
1999
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.
1985
Works of C. Portlock being referenced
Prednisone in MOPP chemotherapy for Hodgkin's disease.
1976
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
2009
Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
1996
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
1999
Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia
1988
Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone.
1998
Establishment of a Human Cell Line (SKI-DLCL-1) with a t(1;14)(q21;q32) Translocation from the Ascites of a Patient with Diffuse Large Cell Lymphoma
2001
Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B
1991
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma
2009
Non-Hodgkin lymphoma: contribution of chest CT in the initial staging evaluation.
1996
Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors.
1997
Targeting the microtubule apparatus in indolent and mantle cell lymphoma with the novel epothilone anlog BMS 247550 induces major and durable remissions in very drug resistant disease
2005
Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.
1988
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
1986
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
1986
Resistance to methotrexate due to gene amplification in a patient with acute leukemia.
1984
High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.
1987